I was constantly sweating." She was also retaining fluid. Elsie soon learned the cause - cardiac amyloidosis. "We used to think of it more as a rare disease," says Dr. Carly Fabrizio of Temple Health.

CAMBRIDGE, Mass., June 09, 2025--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNA interference (RNAi) therapeutics company, today announced that the European Commission (EC) has ...

Indications In the EU, AMVUTTRA ® (vutrisiran) is indicated for the treatment of: hereditary transthyretin amyloidosis in adult patients with stage 1 or stage 2 polyneuropathy (hATTR-PN).

Management of the underlying amyloid disease process is the main treatment. Chemotherapy targeting clonal plasma cells can arrest amyloid formation and lead to regression of deposits, preservation ...

Cardiac involvement depends on the type of amyloid disease. Systemic amyloidosis occurs in more than 10 per million person-years in the USA. It accounts for 1 in 1000 deaths in the British ...

AZ entered the AL amyloidosis arena via its $39 billion takeover of Alexion which closed in July, and said it will acquire the remaining stake in Caelum for $150 million, with another $350 million ...

Alnylam has been a pioneer in hereditary ATTR amyloidosis, getting approval in 2018 for the first drug to treat the rare disease, and has now launched a digital companion to help patients track ...

Florbetaben (18F) has been granted Orphan drug designation for the diagnosis of ATTR amyloidosisFlorbetaben (18F) previously received orphan drug designation as a diagnostic agent for the management ...

Acanthamoeba parasites infect the cornea, the transparent covering of the eye. Without treatment, Acanthamoeba keratitis can lead to severe pain, and in some cases, loss of vision.